Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helge Hasselmann

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
CNS & Neurological Disorders Drug Targets|June 19, 2014
Scopolamine and depression: a role for muscarinic antagonism?Helge Hasselmann
The EPMA Journal|December 2, 2016
The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigueChristian Veauthier, Helge Hasselmann, Stefan M Gold, et al.
The Lancet. Psychiatry|April 12, 2017
Control conditions for randomised trials of behavioural interventions in psychiatry: a decision frameworkStefan M Gold, Paul Enck, Helge Hasselmann, et al.
Frontiers in Immunology|December 12, 2018
Pro-inflammatory Monocyte Phenotype and Cell-Specific Steroid Signaling Alterations in Unmedicated Patients With Major Depressive DisorderHelge Hasselmann, Stefanie Gamradt, Aline Taenzer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 10, 2016
Characterizing the phenotype of multiple sclerosis-associated depression in comparison with idiopathic major depressionHelge Hasselmann, Judith Bellmann-Strobl, Roland Ricken, et al.
Peerj|December 25, 2018
Short-term interval aerobic exercise training does not improve memory functioning in relapsing-remitting multiple sclerosis-a randomized controlled trialLisa Baquet, Helge Hasselmann, Stefan Patra, et al.
Iscience|November 12, 2021
Reduced mitochondrial respiration in T cells of patients with major depressive disorderStefanie Gamradt, Helge Hasselmann, Aline Taenzer, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
CNS & Neurological Disorders Drug Targets|June 19, 2014
Scopolamine and depression: a role for muscarinic antagonism?Helge Hasselmann
The EPMA Journal|December 2, 2016
The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigueChristian Veauthier, Helge Hasselmann, Stefan M Gold, et al.
The Lancet. Psychiatry|April 12, 2017
Control conditions for randomised trials of behavioural interventions in psychiatry: a decision frameworkStefan M Gold, Paul Enck, Helge Hasselmann, et al.
Frontiers in Immunology|December 12, 2018
Pro-inflammatory Monocyte Phenotype and Cell-Specific Steroid Signaling Alterations in Unmedicated Patients With Major Depressive DisorderHelge Hasselmann, Stefanie Gamradt, Aline Taenzer, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 10, 2016
Characterizing the phenotype of multiple sclerosis-associated depression in comparison with idiopathic major depressionHelge Hasselmann, Judith Bellmann-Strobl, Roland Ricken, et al.
Peerj|December 25, 2018
Short-term interval aerobic exercise training does not improve memory functioning in relapsing-remitting multiple sclerosis-a randomized controlled trialLisa Baquet, Helge Hasselmann, Stefan Patra, et al.
Iscience|November 12, 2021
Reduced mitochondrial respiration in T cells of patients with major depressive disorderStefanie Gamradt, Helge Hasselmann, Aline Taenzer, et al.
Pageof 1